Literature DB >> 1898911

Human immune response to Mycobacterium tuberculosis antigens.

D V Havlir1, R S Wallis, W H Boom, T M Daniel, K Chervenak, J J Ellner.   

Abstract

Little is known about the immunodominant or protective antigens of Mycobacterium tuberculosis in humans. Cell-mediated immunity is necessary for protection, and healthy tuberculin-positive individuals are relatively resistant to exogenous reinfection. We compared the targets of the cell-mediated immune response in healthy tuberculin-positive individuals to those of tuberculosis patients and tuberculin-negative persons. By using T-cell Western blotting (immunoblotting) of nitrocellulose-bound M. tuberculosis culture filtrate, peaks of T-cell blastogenic activity were identified in the healthy tuberculin reactors at 30, 37, 44, 57, 64, 71 and 88 kDa. Three of these fractions (30, 64, and 71 kDa) coincided with previously characterized proteins: antigen 6/alpha antigen, HSP60, and HSP70, respectively. The blastogenic responses to purified M. tuberculosis antigen 6/alpha antigen and BCG HSP60 were assessed. When cultured with purified antigen 6/alpha antigen, lymphocytes of healthy tuberculin reactors demonstrated greater [3H]thymidine incorporation than either healthy tuberculin-negative controls or tuberculous patients (8,113 +/- 1,939 delta cpm versus 645 +/- 425 delta cpm and 1,019 +/- 710 delta cpm, respectively; P less than 0.01). Healthy reactors also responded to HSP60, although to a lesser degree than antigen 6/alpha antigen (4,276 +/- 1,095 delta cpm; P less than 0.05). Partially purified HSP70 bound to nitrocellulose paper elicited a significant lymphocyte blastogenic response in two of six of the tuberculous patients but in none of the eight healthy tuberculin reactors. Lymphocytes of none of five tuberculin-negative controls responded to recombinant antigens at 14 or 19 kDa or to HSP70. Antibody reactivity generally was inversely correlated with blastogenic response: tuberculous sera had high titer antibody to M. tuberculosis culture filtrate in a range from 35 to 180 kDa. This is the first systematic evaluation of the human response to a panel of native and recombinant antigens in healthy tuberculin reactors and tuberculous patients. Antigens which stimulated prominent lymphocyte blastogenic responses were identified in seven fractions on T-cell Western blot analysis. Two of these may represent previously characterized proteins; the others may contain immunodominant proteins that will require further characterization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898911      PMCID: PMC257808          DOI: 10.1128/iai.59.2.665-670.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  The BCG story: lessons from the past and implications for the future.

Authors:  P E Fine
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

2.  The identification of T cell epitopes in Mycobacterium tuberculosis using human T lymphocyte clones.

Authors:  J R Lamb; J Ivanyi; A Rees; R A Young; D B Young
Journal:  Lepr Rev       Date:  1986-12       Impact factor: 0.537

3.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

Authors:  P A Selwyn; D Hartel; V A Lewis; E E Schoenbaum; S H Vermund; R S Klein; A T Walker; G H Friedland
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

4.  An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis.

Authors:  E Sada; L E Ferguson; T M Daniel
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

5.  Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies.

Authors:  R S Wallis; S L Alde; D V Havlir; M H Amir-Tahmasseb; T M Daniel; J J Ellner
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.

Authors:  P F Barnes; V Mehra; G R Hirschfield; S J Fong; C Abou-Zeid; G A Rook; S W Hunter; P J Brennan; R L Modlin
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

7.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

8.  The 45 kilodalton molecule of Mycobacterium tuberculosis identified by immunoblotting and monoclonal antibodies as antigenic in patients with tuberculosis.

Authors:  A R Coates; H Nicolai; M J Pallen; A Guy; S D Chaparas; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1989-04

9.  Isolation and characterization of recombinant lambda gt11 bacteriophages expressing eight different mycobacterial antigens of potential immunological relevance.

Authors:  A B Andersen; A Worsaae; S D Chaparas
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli.

Authors:  F Oftung; A S Mustafa; R Husson; R A Young; T Godal
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

View more
  59 in total

1.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Authors:  S A Fulton; J M Johnsen; S F Wolf; D S Sieburth; W H Boom
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Heat-shock proteins, and gamma alpha/delta T cells.

Authors:  R W Finberg
Journal:  Springer Semin Immunopathol       Date:  1991

3.  ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.

Authors:  Xisheng Wang; Peter F Barnes; Karen M Dobos-Elder; James C Townsend; Yoon-tae Chung; Homayoun Shams; Stephen E Weis; Buka Samten
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

4.  In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis.

Authors:  V Hari Sai Priya; B Anuradha; Suman Latha Gaddam; Seyed E Hasnain; K J R Murthy; Vijaya Lakshmi Valluri
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

Review 5.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Detection of pulmonary and extrapulmonary tuberculosis patients with the 38-kilodalton antigen from Mycobacterium tuberculosis in a rapid membrane-based assay.

Authors:  A T Zhou; W L Ma; P Y Zhang; R A Cole
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.

Authors:  R K Katial; J Hershey; T Purohit-Seth; J T Belisle; P J Brennan; J S Spencer; R J Engler
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

8.  Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India.

Authors:  Madhan Kumar; Jagadish C Sundaramurthi; Narinder K Mehra; Gurvinder Kaur; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402

Review 9.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

10.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.